EFFECT OF CHEMOTHERAPY WITH DOCETAXEL / CISPLATIN ON GRANULOCYTIC HEMOPOIESIS IN PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA

Toxic effects of combined cisplatin and docetaxel treatment on the granulocytic hemopoiesis were studied in 45 patients with stage II–IV non-small cell lung carcinoma. The patients received intravenous injections of docetaxel at a dose of 75 mg/m2 followed by cisplatin 75 mg/m2. Blood parameters were assessed during 3 courses of chemotherapy. To estimate the state of granulocytic hemopoiesis, the hematological, cultural and functional methods were used. The study showed that the reactivity of granulocytopoiesis was maintained at a high level, namely, there was a significant activation of the central signals of granulocytic hematopoiesis, resulting in the accumulation of immature and mature myelokaryocytes in the bone marrow and increase in the bone marrow pool of mature neutrophils, as well as in increase in the number of bone marrow progenitor cells granulocytopoiesis in terms of acceleration of their maturing.

1. Lung cancer / Ed. by P. Logrigan, Мoscow; 2009, 196 p. [in Russian]

2. Reutova Е.V., Marenich А.F. Non-small cell lung carcinoma: prospects in chemotherapy. Pulmonology and Allergology. 2011; 3: 3–10. [in Russian]

3. Bagrova S.G., Bychkov М.B., Gorbunova V.А., Kuzminov А.Е.,Naskhletashvili D.R. Comparative assessment of different platinumcontaining chemotherapy regimens in the treatment of advanced nonsmall cell lung carcinoma. Russian Journal of Oncology. 2013; 2: 4–10. [in Russian]

4. Conservative treatment of lung cancer / Ed. by V.А. Gorbunova. Мoscow; 2005, 127 p. [in Russian]

5. Shen G., Bian G., Yu H., Gao M., Kang D., Shen G., Hu S. Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials. Mol Clin Oncol. 2014 Jan; 2 (1): 146–150.

6. Ramalingam S.S., Owonikoko T.K., Khuri F.R. Lung Cancer: New Biological Insights and Recent Therapeutic Advances. CA Cancer J Clin. 2011 Mar-Apr; 61 (2): 91–112. doi: 10.3322/caac.20102.

7. Korolyeva I.А., Kopp М.V., Shaplygin L.V. Prevention and correction of neutropenia and anemia caused by anticancer chemotherapy. Hematology Oncology. Basic Researches and Clinical Practice. 2012; V. 5, № 3: 246–254. [in Russian]

8. Goldberg Е.D., Dygai А.M., Zhdanov V.V., Zuzkov G.N., Guryantseva L.А., Pershina О.V., Simanina Е.V., Skurikhin Е.G., Stavrova L.А., Udut Е.V., Minakova М.Yu., Khrichkova Т.Yu., Firsova Т.V. Theory of hematopoietic regulation and creation of new agents for therapy in hematological malignancies. Bulletin of Experimental Biology and Medicine. 2008; № S2: 6–13. [in Russian]

9. Khrichkova T.Yu., Goldberg V.E., Zhdanov V.V., Popov D.N., Tuzikov S.A., Afanasyev S.G., Dygai A.M. Mechanisms of hematological toxicity of Cisplatin and Xeloda in the conditions of combined therapy of the patients with metastatic gastric cancer. Siberian Scientific Medical Journal. 2005; 4 (118): 64–68. [in Russian]

10. Khrichkova Т.Yu., Goldberg V.Е., Popova N.О., Simolina Е.I., Belevich Yu.V., Zhdanov V.V., Miroshnichenko L.А., Udut Е.V., Simanina Е.V. The mechanisms of filgrastim-induced activation of hematopoietic recovery in breast cancer patients treated with doxorubicin/docetaxel. Siberian Journal of Oncology. 2015; 6: 46–51. [in Russian]

11. Zhdanov V.V., Gur’yantseva L.A., Udut E.V., Khrichkova T.Yu., Simanina E.V., Gol’dberg V.E. Function of hemopoietic stem cells under conditions of cytostatic myelosupression and treatment with hemostimulators. Bull Exp Biol Med. 2005 Nov; 140 (5): 631–4.

12. Goldberg Е.D., Dygai А.M., Zhdanov V.V The role of hematopoiesis-induced microenvironment in hematopoietic regulation in cytostatic myelosupressions. Tomsk: STT; 1999, 128 p. [in Russian]

13. Miroshnichenko L.A., Shdanov V.V., Zyuz’kov G.N., Simanina E.V., Stavrova L.A., Udut E.V., Khrichkova T.Yu., Minakova M.Yu., Goldberg V.E., Dygai A.M. Mechanisms of hemostimulating effects of granulocytic CSF and pantohematogen under conditions of cytostatic myelosupression. Bull Exp Biol Med. 2011 Apr; 150 (6): 702–6.

14. Dygai A.M., Zhdanov V.V., Miroshnichenko L.A., Zyuz’kov G.N., Udut E.V., Simanina E.V., Stavrova L.A., Khrichkova T.Y., Agafonov V.I. Comparison of specific activity of granulocytopoiesis stimulators after treatment with cytostatics with different mechanisms of action. Bull Exp Biol Med. 2013 Sep; 155 (5): 631–5.

15. Vladimirskaya Е.B. Normal hematopoiesis and its regulation. Clinical Hematology Oncology. 2015; 8 (2): 109–119. [in Russian]

16. Pokrovskaya О.S. The mechanism and clinical efficacy of Plerixafor, a CXCR4 antagonist, antagonist,in mobilization of hematopoietic stem cells. Clinical Hematology Oncology. Basic Researches and Clinical Practice. 2012, 5 (4): 371–379. [in Russian]

17. Fiala M.A., Park S., Slade M., DiPersio J.F., Stockerl-Goldstein K.E. Remobilization of hematopoietic stem cells in healthy donors for allogeneic transplantation. Transfusion. 2016 Sep; 56 (9): 2331–5. doi: 10.1111/trf.13688.

18. Pokrovsky V.S., Treshchalina Е.М., Bychkov М.B. Prospect in the development of combined chemotherapy for disseminated small cell lung carcinoma. Russian Biological Therapy Journal. 2009. 8 (3): 61–68. [in Russian]